• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Mass exodus to Questcor and Genzyme WTH....?

















Great! you got to feel real good selling a drug that treats epilepsy in babies and jacking up the price from $2500 to $25,000. All you do is grease the right people to prescribe a 50 yr old dog. What steroids don't work anymore? Acthar Gel is really filling an unmet medical need. Right! Enjoy your dinners and your autonomy. You got a year or two left. Ever hear of a thing called healthcare reform? or conscience?

OK dipshit, let's do the math. Avonex launched in 1997 and sold for around 6 grand. Flash forward 15 years, now sells for over 40 grand. So do you feel good?

Enjoy your pod!
 




Avonex actually treats a medical condition, MS. Unlike the swamp water that the MD's you are paying have all of a sudden told patients that can't live without. Can you say Office of the Inspector General, dipshit.